Detalhe da pesquisa
1.
The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer.
Cell
; 184(12): 3143-3162.e32, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34004147
2.
Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition.
Mol Cell
; 81(10): 2183-2200.e13, 2021 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34019788
3.
Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma.
Haematologica
; 106(7): 2013-2017, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33375771
4.
Molecular Mechanisms of Cereblon-Interacting Small Molecules in Multiple Myeloma Therapy.
J Pers Med
; 11(11)2021 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34834536
5.
CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory.
Cancer Discov
; 11(10): 2582-2601, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33990344
6.
Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and ß-catenin survival signaling pathways.
Oncotarget
; 8(9): 14604-14619, 2017 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28099937